Navigation Links
New Initiative Has Shocking Effect: Thousands of Missourians with Abnormal Chromosome Structures Are Not Human
Date:8/27/2007

ST. LOUIS, Aug. 27 /PRNewswire-USNewswire/ -- Missouri Coalition for Lifesaving Cures revealed today a consequence of the deceptive and far- reaching initiative petition filed last week by opponents of embryonic stem cell research: It is so poorly worded and scientifically unsound that it would exclude Missourians with common chromosomal abnormalities like Down, Klinefelter and Turner syndromes from its definition of "human."

In their blind rush to put their personal ideology ahead of Missourians' need for lifesaving cures, opponents of stem cell research have trampled basic science. Said chief medical officer of St. Louis Children's Hospital Dr. F. Sessions Cole, "It's impossible to know all the consequences of this vague and poorly written initiative, but there's one that's immediately clear. If you're one of the thousands of Missourians with a chromosome abnormality, this initiative declares you not to be human and enshrines that definition into our constitution. I find that deeply troubling, and I suspect most Missourians will as well."

The initiative states: "(2) For all purposes within this Constitution, "Human organism" means human life in any stage. Human life begins with an initial stage, when a single human egg cell receives a complete set of forty- six chromosomes, and continues through any subsequent stages of embryonic, fetal, postnatal, and later development."

Many common genetic diseases occur when a deviation occurs in the number of chromosomes transferred. In addition to citizens with 47 chromosomes who suffer from Down syndrome, and individuals with Turner syndrome who usually have 45 chromosomes, countless other Missourians with various genetic disorders do not have a "complete set" of genetic information through small chromosomal variations.

Added Dena Ladd, a longtime child and patient advocate, "It's bad enough that this initiative's supporters would ban some of the most promising stem cell research and potentiall
'/>"/>

SOURCE Missouri Coalition for Lifesaving Cures
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Handicapping Milwaukees wireless initiative
2. WHIE receives state eHealth Initiative contract
3. Healthcare quality initiative shuns high-tech for now
4. State initiative prepares Wisconsin IT systems for a disaster
5. Wisconsin plant is part of NCRs global RFID initiative
6. Milwaukee announces citywide wireless initiative
7. California stem cell initiative should wake up Washington and Madison
8. Federal funding to drive Racine tech transfer initiative
9. GE Launches Womens Health Initiative
10. The Milkweed Effect: Disseminating Technology to New Regions
11. Creating thousands of jobs, Chicagos biotech space to triple
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... China Biologic Products, Inc. (NASDAQ: CBPO, ... integrated plasma-based biopharmaceutical company in China ... Shandong Taibang Biological Products Co. Ltd., has received ... Food and Drug Administration (the "CFDA") for its ... in the Company,s public filings, the CFDA inspected ...
(Date:12/24/2014)... 2014  Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... Clinical Trial Application (CTA) with the United ... seeking regulatory approval to initiate clinical trials for the ... Contingent on the Company receiving CTA regulatory approval, ... to assess the safety, tolerability and dose escalation of ...
(Date:12/22/2014)... 22, 2014 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: ... focused on the development of autologous cell therapies, announced ... University of Calgary in conjunction with co-authors from Kyoto ... validates the company,s ongoing clinical research using dermal sheath ... baldness. The paper entitled " Hair Follicle ...
(Date:12/22/2014)... 22, 2014 The American ... of original research, reviews and editorials addressing developments ... practice, today published a provocative article exploring the ... progression and potential treatment of prostate cancer. ... and proposes the possibility that there could be ...
Breaking Biology Technology:China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4
... ROCKVILLE, Md., May 5 Sequella, Inc., a clinical-stage ... today the start of its Phase 1B trial for ... volunteers. SQ109, a new diamine antibiotic intended to replace ... and simplify patient therapy, was granted U.S. FDA Fast ...
... Mass., May 5 Syrinx Consulting Corporation ... that delivers easy-to-use .Net and SharePoint applications ... contract for approximately $100,000 with a leading biopharmaceutical company ... migrating thousands of users and gigabytes of data from ...
... Breakthrough biotechnology research is providing new applications ... and diabetes, two leading health concerns among consumers. ... Advana Science, www.advanascience.com , will ... this dynamic consumer healthy category at VitaFoods International ...
Cached Biology Technology:Sequella Commences Phase 1B Study for New Tuberculosis Drug SQ109 2Syrinx Wins Contract with Leading Pharmaceutical Company for SharePoint 2007 Services 2Industry Expert Reveals Cutting Edge Biotechnology Science for Nutraceutical and Functional Food Applications 2
(Date:12/19/2014)... Research and Markets ( http://www.researchandmarkets.com/research/8kmfcn/iphone_5s ... "iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... July 2012, Apple introduced the fingerprint reading feature ... only device of Apple incorporating such a feature, ...
(Date:12/17/2014)... Dec. 15, 2014 The Defense Logistics ... easier to detect and prevent counterfeit microcircuits from ... the agency started performing an in-house microcircuit anti-counterfeit ... the authenticity of purchased microcircuits while increasing their ... control measures will be conducted at DLA,s Electronics ...
(Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... addition of the "Global Facial Recognition Market ... http://photos.prnewswire.com/prnh/20130307/600769 Facial ... of individuals. Facial recognition system measures the overall ... jaw edges, mouth, and the distance between eyes. ...
Breaking Biology News(10 mins):iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... fund structured by JPMorgan Chase & Co. (NYSE: JPM) ... the first time, allow individual and institutional investors the ... the potential to save millions of lives in low-income ... pioneering group of investors including anchor support from ...
... imply that it is hard to fool the brain by ... sweet solutions is driven to a great extent by the ... is attributed to sugars compared to artificial sweeteners. Professor ... School of Medicine USA, says:,"The consumption of high-calorie beverages is ...
... vaccine after using the 2009 pandemic as a natural experiment ... Researchers at Imperial College London asked volunteers to donate ... underway and report any symptoms they experienced over the next ... severe illness had more CD8 T cells, a type of ...
Cached Biology News:New investment fund will advance late-stage vaccines, other global health technologies 2New investment fund will advance late-stage vaccines, other global health technologies 3New investment fund will advance late-stage vaccines, other global health technologies 4The brain cannot be fooled by artificial sweeteners 2Scientists closer to universal flu vaccine after pandemic 'natural experiment' 2
DITHIOTHREITOL, 150UMOL, 1 EA. Dithiothreitol (DTT), 0.1 M Solution:, *0.1 M solution of DTT in high purity dH2O., *0.2 m filtered., *Storage: -20C. Category: SEQUENASE....
... Dithiothreitol, 1 g. High ... convenient sample preparation that give ... disrupt cells and tissues.Clean up ... sample volumes. Accurately quantitate protein ...
ANTI 5-HYDROXYTRYPTOPHAN CONJ....
IMAGEQUANT 400 WKSTN, 1 EA. Category: ImageQuant CCD Imagers....
Biology Products: